Clinical effects of allylestrenol (Perselin®) on benign prostatic hypertrophy evaluated by the measures of prostatic volume, urodynamics and sexual function

T. Amano, H. Noma, T. Omoto, H. Yagi, T. Kurozumi, S. Sakuma, Y. Abe, H. Kuramoto, N. Tokuda, K. Ito, Akira Yokomizo, M. Sakumoto, K. Ishida, S. Ando, K. Hokamura, E. Okada, H. Nagayoshi, H. Hirano, S. Sato

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)616-628
Number of pages13
JournalNishinihon Journal of Urology
Volume55
Issue number4
Publication statusPublished - Jan 1 1993

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Amano, T., Noma, H., Omoto, T., Yagi, H., Kurozumi, T., Sakuma, S., Abe, Y., Kuramoto, H., Tokuda, N., Ito, K., Yokomizo, A., Sakumoto, M., Ishida, K., Ando, S., Hokamura, K., Okada, E., Nagayoshi, H., Hirano, H., & Sato, S. (1993). Clinical effects of allylestrenol (Perselin®) on benign prostatic hypertrophy evaluated by the measures of prostatic volume, urodynamics and sexual function. Nishinihon Journal of Urology, 55(4), 616-628.